446292-08-6
- Product Name:Rivaroxaban intermediate
- Molecular Formula:C22H19N3O6
- Purity:99%
- Molecular Weight:421.409
Product Details:
CasNo: 446292-08-6
Molecular Formula: C22H19N3O6
Appearance: White solid
Chinese Factory Supply Reliable Quality Rivaroxaban intermediate 446292-08-6 Lowest Price
- Molecular Formula:C22H19N3O6
- Molecular Weight:421.409
- Appearance/Colour:White solid
- Vapor Pressure:0mmHg at 25°C
- Melting Point:250
- Refractive Index:1.658
- Boiling Point:702.933 °C at 760 mmHg
- PKA:0.99±0.20(Predicted)
- Flash Point:378.92 °C
- PSA:96.46000
- Density:1.466 g/cm3
- LogP:1.73910
Rivaroxaban intermediate (Cas 446292-08-6) Usage
Description | Rivaroxaban advanced intermediates are a class of drugs used to treat and prevent blood clots. Rivaroxaban is also known as Xarelto and is used as an oral anticoagulant in many medical formulations. |
Uses |
1H-isoindole-1,3(2H)-dione, 2-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- is an important intermediate for the synthesis of rivaroxaban, which is an anticoagulant and the first orally active direct factor Xa inhibitor. |
Chemical Properties |
White Solid |
Flammability and Explosibility |
Nonflammable |
InChI:InChI=1/C22H19N3O6/c26-19-13-30-10-9-23(19)14-5-7-15(8-6-14)24-11-16(31-22(24)29)12-25-20(27)17-3-1-2-4-18(17)21(25)28/h1-8,16H,9-13H2/t16-/m1/s1
446292-08-6 Relevant articles
A review on the synthetic approaches of rivaroxaban: An anticoagulant drug
Tanzeela Abdul Fattah, Aamer Saeed
Tetrahedron: Asymmetry Volume 28, Issue 4, 15 April 2017, Pages 485-504
This review comprehensively provides an overview of the various asymmetric synthetic methods employed for the synthesis of rivaroxaban in high yields and stereoselectivity describing the various chiral synthons used in the synthetic process along with pros and cons of each method. In addition, methods for the industrial production of rivaroxaban have been highlighted in the manuscript.
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Wolfgang Mueck, Jan Stampfuss, Dagmar Kubitza & Michael Becka
,Clinical Pharmacokinetics, Volume 53, pages 1–16, (2014)
Variability in the pharmacokinetic parameters is moderate (coefficient of variation 30–40 %). The pharmacokinetic profile of rivaroxaban is consistent in healthy subjects and across a broad range of different patient populations studied.
446292-08-6 Process route
- 1325210-64-7
4-(4-isocyanatophenyl)morpholin-3-one
- 161596-47-0
(S)-N-glycidylphthalimide
- 446292-08-6,1424944-35-3
2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
Conditions | Yield |
---|---|
With 3-methyl-1-butyl acetate; magnesium chloride; at 120 ℃; for 4h; Solvent; Reagent/catalyst; Temperature;
|
95.5% |
With lithium iodide; In chlorobenzene; at 115 ℃; for 4h; Reagent/catalyst; Solvent; Temperature;
|
94.09% |
- 634905-12-7
4-(4-bromophenyl)morpholin-3-one
-
(S)-2-[[2-oxo-1,3-oxazolidin-5-yl]methyl]-1H-isoindole-1,3(2H)-dione
- 446292-08-6,1424944-35-3
2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
Conditions | Yield |
---|---|
With copper(l) iodide; N,N-dimethyl-ethanamine; potassium carbonate; In dichloromethane; at 100 ℃; for 15h; Solvent; Reagent/catalyst; Sealed tube;
|
92.2% |
With copper(l) iodide; N,N-dimethyl-ethanamine; potassium carbonate; In dichloromethane; at 100 ℃; for 15h; Sealed tube;
|
92.5% |
446292-08-6 Upstream products
-
446292-07-5
2-((2S)-2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione
-
530-62-1
1,1'-carbonyldiimidazole
-
161596-47-0
(S)-N-glycidylphthalimide
-
438056-69-0
4-(4-aminophenyl)morpholin-3-one
446292-08-6 Downstream products
-
446292-10-0
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one
-
366789-02-8
Rivaroxaban
Relevant Products
-
Apixaban
CAS:503612-47-3
-
Rimegepant
CAS:1289023-67-1
-
Mirodenafil
CAS:862189-95-5